| Improving insulin sensitivity via activation of PPAR-gamma increases telomerase activity in the heart of OLETF rats. | |
| | |
MedLine Citation:
|
PMID: 19855065 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
This study was conducted to examine telomere biology in terms of improving insulin sensitivity in a type 2 diabetic animal model: Otsuka Long-Evans Tokushima fatty (OLETF) rats. To improve insulin sensitivity, pioglitazone (PG; 10 mg.kg(-1).day(-1)) was administrated to OLETF rats from 20 to 40 wk of age, and the effects of treatment were compared with those in untreated OLETF or control Long-Evans Tokushima Otsuka fatty rats. At the end of the study, the homeostasis model assessment of insulin resistance significantly increased in OLETF rats but decreased in OLETF rats treated with PG. No shortening of telomere length was observed in the heart tissue of OLETF rats, whereas telomerase activity was decreased in OLETF heart tissue. The mRNA expression of both telomerase reverse transcriptase and telomere repeat binding factor 2 was downregulated in the hearts of OLETF rats. The protein expression of phospho-Akt, insulin-like growth factor, and endothelial nitric oxide synthase was reduced in OLETF rats. On the other hand, myocardial matrix metalloproteinase-9 expression was elevated in OLETF rats. The changes observed in OLETF rats were inhibited by PG treatment. However, protein and mRNA expression of Sirt1, a lifespan modulator, were attenuated in OLETF rat hearts, although they were enhanced in OLETF rats with PG treatment. Myocardial fibrosis was less extensive and diastolic dysfunction more greatly ameliorated in PG-treated OLETF rats than in OLETF rats. These findings suggest that improving insulin sensitivity via the activation of peroxisom proliferator-activated receptor-gamma may exert regulatory effects on cardiac telomere biology and may have desirable morphological and functional effects on the diabetic heart. |
| | |
Authors:
|
Naoki Makino; Toyoki Maeda; Jun-ichi Oyama; Yosihiro Higuchi; Koji Mimori |
Related Documents
:
|
8323545 - A novel [99m]technetium-labeled nitroheterocycle capable of identification of hypoxia i... 12106595 - Rats fed a high sucrose diet have altered heart antioxidant enzyme activity and gene ex... 3834915 - Heart-rate responses of infant rats and guinea pigs to stimulus onset and offset: tests... 202145 - Role of the adrenergic nervous system in development of training-induced bradycardia. 2864245 - Elastin metabolism during perinatal lung development in the copper-deficient rat. 1242575 - Adrenocortical responses following sciatic nerve stimulation in rats with partial hypot... |
Publication Detail:
|
Type: Journal Article; Research Support, Non-U.S. Gov't Date: 2009-10-23 |
Journal Detail:
|
Title: American journal of physiology. Heart and circulatory physiology Volume: 297 ISSN: 1522-1539 ISO Abbreviation: Am. J. Physiol. Heart Circ. Physiol. Publication Date: 2009 Dec |
Date Detail:
|
Created Date: 2009-11-25 Completed Date: 2010-02-17 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 100901228 Medline TA: Am J Physiol Heart Circ Physiol Country: United States |
Other Details:
|
Languages: eng Pagination: H2188-95 Citation Subset: IM |
Affiliation:
|
Division of Molecular and Clinical Gerontology, Department of Molecular and Cellular Biology, Medical Institute of Bioregulation, Kyushu University, 4546 Tsurumihara, Beppu 874-0838, Japan. makinon@beppu.kyushu-u.ac.jp |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Adipose Tissue
/
enzymology Animals Diabetes Mellitus, Type 2 / drug therapy*, enzymology, genetics, physiopathology Disease Models, Animal Fibrosis Hypoglycemic Agents / administration & dosage, pharmacology* Insulin Resistance* Liver / enzymology Male Matrix Metalloproteinase 9 / metabolism Muscle, Skeletal / enzymology Myocardial Contraction / drug effects Myocardium / enzymology*, pathology Nitric Oxide Synthase Type III / metabolism PPAR gamma / agonists* Phosphorylation Proto-Oncogene Proteins c-akt / metabolism RNA, Messenger / metabolism Rats Rats, Inbred OLETF Sirtuin 1 / metabolism Somatomedins / metabolism Telomerase / genetics, metabolism* Telomeric Repeat Binding Protein 2 / metabolism Thiazolidinediones / administration & dosage, pharmacology* Up-Regulation |
| Chemical | |
Reg. No./Substance:
|
0/Hypoglycemic Agents; 0/PPAR gamma; 0/RNA, Messenger; 0/Somatomedins; 0/Telomeric Repeat Binding Protein 2; 0/Thiazolidinediones; 111025-46-8/pioglitazone; EC 1.14.13.39/Nitric Oxide Synthase Type III; EC 1.14.13.39/Nos3 protein, rat; EC 2.7.11.1/Proto-Oncogene Proteins c-akt; EC 2.7.7.49/Telomerase; EC 3.4.24.35/Matrix Metalloproteinase 9; EC 3.5.1.-/Sirt1 protein, rat; EC 3.5.1.-/Sirtuin 1 |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Stress-induced Senescence Exaggerates Post Injury Neointimal Formation in the Old Vasculature.
Next Document: Nonanticoagulant heparin reduces myocyte Na+ and Ca2+ loading during simulated ischemia and decrease...